MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Neurology, Psychology, Mental Health, CNS, Pain & TBI Companies (Pharmaceuticals, Drugs, Biotechnology, Biosimilars) _ Neurodegenerative; Neuromuscular, Neuropsychiatric
Inhibikase Therapeutics, Inc. (NASDAQ: IKT)*
Organization & Developments: Inhibikase Therapeutics
Parents
Inhibikase Therapeutics, Inc. (NASDAQ: IKT)*
Children
*Inhibikase Therapeutics, Inc. (Nasdaq: IKT) (Inhibikase), a clinical-stage pharmaceutical company developing therapeutics to modify the course of Parkinson's disease and related disorders
2024: Inhibikase: Potential To Improve Current Treatment Options For PAH Patients_ seekingalpha.com
Jumps
Finance & Acquisitions: Inhibikase Therapeutics
Key People: Inhibikase Therapeutics